Citigroup »

Trisalus Life Sciences shares owned by Citigroup

Quarter-by-quarter ownership of Trisalus Life Sciences (TLSI) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Trisalus Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Trisalus Life Sciences held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trisalus Life Sciences by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.3k 2.1k 4.00
2025-03-31 $5.3k 958 5.52

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Trisalus Life Sciences

First Light Asset Management
AWM Investment Company
Nantahala Capital Management
Vanguard Group
BlackRock
Daniel D. Thurber
Vanguard Capital Management
Gilder, Gagnon, Howe & Co
HPM Partners
Geode Capital Management
Thompson, Siegel, & Walmsley
Kennedy Capital Management
Morgan Stanley
Empire Financial Management Company
State Street Corporation

View all funds holding Trisalus Life Sciences